XML 17 R5.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Common stock
Initial stockholder sale on February 15, 2018
Common stock
Private placement on May 18, 2018
Common stock
Private placement on May 29, 2018
Common stock
IPO
Common stock
Over-allotment option
Common stock
Additional Paid-in Capital
Initial stockholder sale on February 15, 2018
Additional Paid-in Capital
Private placement on May 18, 2018
Additional Paid-in Capital
Private placement on May 29, 2018
Additional Paid-in Capital
IPO
Additional Paid-in Capital
Over-allotment option
Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Initial stockholder sale on February 15, 2018
Private placement on May 18, 2018
Private placement on May 29, 2018
IPO
Over-allotment option
Total
Balance at beginning of period at Jan. 22, 2018           $ 0           $ 0 $ 0           $ 0
Balance at beginning of period (in shares) at Jan. 22, 2018           0                          
CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY                                      
Issuance of common stock $ 575 $ 80 $ 9 $ 2,000 $ 300   $ 24,425 $ 7,999,920 $ 899,991 $ 195,353,378 $ 29,399,700     $ 25,000 $ 8,000,000 $ 900,000 $ 195,355,378 $ 29,400,000  
Issuance of common stock (in shares) 5,750,000 800,000 90,000 20,000,000 3,000,000                            
Common stock subject to possible redemption           $ (2,283)           (230,591,129)             (230,593,412)
Common stock subject to possible redemption (in shares)           (22,831,030)                          
Net income                         1,913,035           1,913,035
Balance at end of period at Dec. 31, 2018           $ 681           3,086,285 1,913,035           $ 5,000,001
Balance at end of period (in shares) at Dec. 31, 2018           6,808,970                         6,808,970
CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY                                      
Common stock subject to possible redemption           $ 28           1,913,007 (4,643,494)           $ (2,730,459)
Common stock subject to possible redemption (in shares)           278,889                          
Net income                         $ 2,730,459           2,730,459
Balance at end of period at Dec. 31, 2019           $ 709           $ 4,999,292             $ 5,000,001
Balance at end of period (in shares) at Dec. 31, 2019           7,087,859                         7,087,859